Tiziana Life Sciences Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 17.69 million compared to USD 15.4 million a year ago. Basic loss per share from continuing operations was USD 0.173 compared to USD 0.152 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | 0.00% | +0.01% | +78.57% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+78.57% | 102M | |
+51.85% | 57.87B | |
+41.28% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Ltd Reports Earnings Results for the Full Year Ended December 31, 2023